Related Experiment Videos
Long-lasting decrease in neuronal Ca2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal
R E Blair1, S B Churn, S Sombati
1Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0599, USA.
Brain Research
|January 22, 2000
Summary
Ca2+/calmodulin-dependent protein kinase II (CaM Kinase II) activity decreases during epileptogenesis. This reduction in CaM Kinase II function may contribute to the development and persistence of spontaneous recurrent seizures in hippocampal cultures.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Epileptiform activity, characterized by spontaneous recurrent seizures (SRSs), is a hallmark of epilepsy.
- Ca2+/calmodulin-dependent protein kinase II (CaM Kinase II) plays critical roles in neuronal function and plasticity.
Purpose of the Study:
- To investigate the activity of CaM Kinase II in an in vitro model of epileptiform activity.
- To determine if CaM Kinase II activity is altered during the induction and maintenance of SRSs.
Main Methods:
- Induction of SRSs in hippocampal neuronal cultures using low Mg2+ media.
- Analysis of endogenous Ca2+/calmodulin-dependent phosphorylation of CaM Kinase II subunits.
- Assay of CaM Kinase II substrate phosphorylation using synthetic peptides (Autocamtide-2, Syntide II).
Main Results:
- A significant, long-lasting decrease in CaM Kinase II activity was observed following SRS induction.
- Reduced phosphorylation of CaM Kinase II alpha and beta subunits correlated with SRS activity.
- Decreased substrate phosphorylation persisted throughout the neurons' lifespan in culture and was not due to enhanced phosphatase activity.
Conclusions:
- CaM Kinase II activity is significantly reduced in hippocampal cultures exhibiting epileptogenesis.
- This diminished CaM Kinase II activity may be a contributing factor to the generation and maintenance of SRSs.
- The findings suggest a potential role for CaM Kinase II dysregulation in epilepsy pathogenesis.